Aclarion, Inc. (ACONW) community

ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 8/30

$0.02+0.00 (0.00%)

Close on Oct 30, 2026Market cap $5.62MP/E –Yield –

Community

Notes and questions about Aclarion from other investors

No posts about ACONW yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Aclarion's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-9047 reverse split on Apr 9, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ACONW.

Compare: ACONW vs SERA · ACONW vs ADVB · ACONW vs YDES · ACONW vs BRTX · ACONW vs PFSA

Revenue growth33.1% · median -21.8%

Gross margin21.8% · median -29.0%

Operating margin-11592.1% · median -28628.9%

Net margin-10978.5% · median -25282.6%

Company	Revenue	Growth
BRTX	$357.87K	-8.5%
ACONW	$83.77K	+33.1%
SERA	$70.00K	-35.2%
ADVB	–	–
YDES	–	–
PFSA	–	–

Company

Exchange: Nasdaq
Industry: Services-Medical Laboratories
Fiscal year ends: December 31
Employees: 11
Auditor: Haynie & Company
SEC CIK: 1635077

Advertisement
300 × 250